Is Prebiotic Skin Health Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Prebiotic Skin Health Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - It is postulated that, apart from genetic predisposition, the rise of local and systemic immune response in PS could be a consequence of intestinal dysbiosis associated with increased intestinal permeability. [Krupa-Kozak U (2026); evidence level 2] - We expect that the RCT results will enable the introduction of personalised dietary therapy with prebiotic ITFs, which, unlike other PS therapies, would not pose a high risk of side effects. [Krupa-Kozak U (2026); evidence level 2] - BACKGROUND: A strong, bidirectional association exists between gastrointestinal health and skin homeostasis in many chronic skin inflammations, including psoriasis (PS). [Krupa-Kozak U (2026); evidence level 2] - objective Theof this paper is to analyze the available scientific evidence on the cutaneous microbiome and its relationship with skin health. [Taléns‐Visconti Raquel (2026); evidence level 4] - acnes 14 15 16 2 15 12 12 2 3 3 17 18 19 13 15 16 The skin microbiome shifts notably throughout life, from the low diversity observed in newborns, to the emergence of lipophilic species with puberty, and typically an increase in overall alpha diversity in older adults due to reduced dominance of protective commensals such asand, coupled with higher representation of environmental/transient species [,]. [Taléns‐Visconti Raquel (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.